nimacimab glp-1 news A first-in-class antisense oligonucleotide — RES-010 (Resalis Therapeutics, Turin, Italy) — may complement and enhance the efficacy of antiobesity drugs such as receptor agonists (RAs), preclinical experiments and an ongoing phase Skye Bioscience Q2 2025 slides:

Nutrapharm launches Setria-powered supplement, marking a regulatory milestone for the clinically researched ingredient in South America NEW YORK, June 11, 2026 /PRNewswire/ -- Kyowa Hakko, a global leader in health ingredient innovation and manufacturer of branded ingredient Setria Glutathione, today announced that a supplement featuring Setria has been approved for sale in Chile through the Secretara Regional Ministerial (SEREMI) de Salud

however, theres a high amount of sugar for anyone watching their calories or sugar intakeeven in the 8.4-ounce can, with 27 grams of sugar

Brain-targeted melanocortin receptor activation desire begins where it should Pricing: View PT-141 pricing and purchase directly through the Prestige App

As a result of their research, the group in Copenhagen independently came to essentially the same conclusion as the Boston team that the biological activity of GLP-1 lay in a truncated form of the peptide which they identified as starting at residue 78 on the peptides sequence (Holst 2019